InvestSMART

Algorae Pharmaceuticals Limited (ASX: 1AI) - Announcements

- Current share price for 1AI : $0.008

ASX company news and announcements for Algorae Pharmaceuticals Limited (1AI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Algorae Pharmaceuticals Limited (1AI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Algorae Pharmaceuticals Limited (1AI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Algorae Pharmaceuticals Limited (1AI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$16 Algorae Expands AI Drug Combination Pipeline 18 May 2026 8:54AM $0.013 $0.008 fallen by 38.46%
$16 1AI Executes License & Supply Agreement with Torrent Pharma 6 May 2026 8:54AM $0.014 $0.008 fallen by 42.86%
$16 Quarterly Activities Report /Appendix 4C Cash Flow Statement 30 Apr 2026 8:39AM $0.014 $0.008 fallen by 42.86%
$16 Algorae and Zydus Enter Exclusive Commercial Agreement 28 Apr 2026 8:35AM $0.012 $0.008 fallen by 33.33%
$16 Investor Webinar 21 Apr 2026 8:37AM $0.012 $0.008 fallen by 33.33%
$16 Cleansing Notice 7 Apr 2026 5:23PM $0.013 $0.008 fallen by 38.46%
$16 Notification regarding unquoted securities - 1AI 7 Apr 2026 5:17PM $0.013 $0.008 fallen by 38.46%
$16 Application for quotation of securities - 1AI 7 Apr 2026 5:13PM $0.013 $0.008 fallen by 38.46%
$16 Application for quotation of securities - 1AI 7 Apr 2026 5:13PM $0.013 $0.008 fallen by 38.46%
$16 Proposed issue of securities - 1AI 2 Apr 2026 5:14PM $0.016 $0.008 fallen by 50%
$16 Algorae Pharmaceuticals Ltd Raises $3.9m 2 Apr 2026 5:08PM $0.016 $0.008 fallen by 50%
$16 TGA Accepts Initial Registration Dossier for Evaluation 2 Apr 2026 9:38AM $0.017 $0.008 fallen by 52.94%
$16 Peter Mac Partners with Algorae on AI Validation 30 Mar 2026 8:56AM $0.017 $0.008 fallen by 52.94%
$16 Cleansing Notice 27 Mar 2026 6:15PM $0.017 $0.008 fallen by 52.94%
$16 Application for quotation of securities - 1AI 27 Mar 2026 6:10PM $0.017 $0.008 fallen by 52.94%
$16 Appointment of Mr Waleed Elsayed as Head of Sales 20 Mar 2026 9:00AM $0.015 $0.008 fallen by 46.67%
$16 Cleansing Notice 13 Mar 2026 6:37PM $0.015 $0.008 fallen by 46.67%
$16 Application for quotation of securities - 1AI 13 Mar 2026 6:31PM $0.015 $0.008 fallen by 46.67%
$16 Notification regarding unquoted securities - 1AI 13 Mar 2026 6:29PM $0.015 $0.008 fallen by 46.67%
$16 Notification regarding unquoted securities - 1AI 13 Mar 2026 6:23PM $0.015 $0.008 fallen by 46.67%
$16 Initial Director's Interest Notice 12 Mar 2026 6:41PM $0.014 $0.008 fallen by 42.86%
$16 Final Director's Interest Notice 12 Mar 2026 6:34PM $0.014 $0.008 fallen by 42.86%
$16 Algorae appoints Mr David Gulland to its Board of Directors 10 Mar 2026 8:57AM $0.014 $0.008 fallen by 42.86%
$16 Notification regarding unquoted securities - 1AI 5 Mar 2026 6:25PM $0.016 $0.008 fallen by 50%
$16 Change of Director's Interest Notice - DH 5 Mar 2026 6:20PM $0.016 $0.008 fallen by 50%

26 - 50 of 193 results

Page 2 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.